정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
---|---|---|---|---|---|---|---|---|---|---|---|
2487 | Active, not recruiting | A Phase II Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Exosomes Overexpressing CD24 to Prevent Clinical Deterioration in Patients With Moderate or Severe COVID-19 Infection | COVID-19 Disease | Drug: Exosomes overexpressing CD24 | Phase 2 | Eli Sprecher, MD, OBCTCD24 Ltd | OTHER_GOV | 155 | All | 18 Years ~ 80 Years | Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel |
2486 | Recruiting | A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19 | Covid19 | Biological: hMSC | Phase 2 | Stemedica Cell Technologies, Inc., bioRASI, LLC | INDUSTRY | 40 | All | 18 Years | Providence Medical Foundation, Fullerton, California, United States Providence Saint John's Health Center - Saint John's Cancer Institute, Santa Monica, California, United States |
2485 | Completed | A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19 | Coronavirus Infection | Drug: ArtemiC Drug: Placebo |
Phase 2 | MGC Pharmaceuticals d.o.o | INDUSTRY | 50 | All | 18 Years | Mahatma Gandhi Mission Medical College and Hospital, Aurangabad, Maharashtra, India Hillel Yaffe Medical Center, Hadera, Haifa, Israel Nazareth Hospital EMMS, Nazareth, North, Israel Rambam Health Care Campus, Haifa, Israel |
2484 | Completed | A Phase II/III Study of Sargramostim | COVID-19 | Drug: Sargramostim Drug: Placebo |
Phase 3 | Nobelpharma | INDUSTRY | 70 | All | 20 Years ~ 85 Years | IUHW Narita Hospital, Narita City, Chiba, Japan Kanagawa Cardiovascular and Respiratory Center, Yokohama City, Kanagawa, Japan Japanese Red Cross Society Saitama Red Cross Hospital, Saitama City, Saitama, Japan St. Luke's International Hospital, Chuo-ku, Tokyo, Japan Mishuku Hospital, Meguro-ku, Tokyo, Japan Japanese Red Cross Medical Center, Shibuya-ku, Tokyo, Japan Center Hospital of the National Center for Global Health and Medicine, Shinjuku-Ku, Tokyo, Japan |
2483 | Not yet recruiting | A Phase III Clinical Study of a SARS-CoV-2 Messenger Ribonucleic Acid (mRNA) Vaccine Candidate Against COVID-19 in Population Aged 18 Years and Above | SARS-CoV-2 | Biological: SARS-CoV-2 mRNA Vaccine Biological: Placebo |
Phase 3 | Walvax Biotechnology Co., Ltd., Abogen Biosciences Co. Ltd., Yuxi Walvax Biotechnology Co., Ltd. | INDUSTRY | 28000 | All | 18 Years | |
2482 | Not yet recruiting | A Phase III Clinical Trial of the Immunogenicity and Safety of the Gam-COVID-Vac Vaccine Against COVID-19 in the UAE | SARS-CoV Infection | Biological: Gam-COVID-Vac Other: placebo |
Phase 3 | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation, PDC-CRO | OTHER | 1000 | All | 18 Years | |
2481 | Recruiting | A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19 | Safety and Efficacy | Biological: Recombinant new coronavirus vaccine (CHO cell) group Biological: Recombinant new coronavirus vaccine (CHO cells) placebo group |
Phase 3 | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | INDUSTRY | 29000 | All | 18 Years | Hunan Provincial Center for Disease Control and Prevention, Changsha, Hunan, China Biodimed Guayaquil Clinical Research Center, Guayaquil, Guayas, Ecuador Biodimed Alemania Clinical Research Center, Quito, Pichincha, Ecuador Biodimed Eloy Alfaro Clinical Research Center, Quito, Pichincha, Ecuador Fkui-Rscm, Jakarta, Daerah Khusus Ibukota Jakarta, Indonesia FK Unpad/RSHS, Bandung, Jawa Barat, Indonesia Aziz Fatimah Hospital, Faisalabad, Punjab, Pakistan Al-Shifa Trust Eye Hospital, Lahore, Punjab, Pakistan Avicenna Hospital, Lahore, Punjab, Pakistan Central Park Medical college, Lahore, Punjab, Pakistan National Hospital & Medical Center, Lahore, Punjab, Pakistan University of Health Sciences, Lahore, Punjab, Pakistan Indus Hospital, Karachi, Sindh, Pakistan Shaheed Zulfiqar Ali Bhutto Medical University, Islamabad, Pakistan Family Hospital No.15, Tashkent, Uzbekistan GUVD Poliklinika, Tashkent, Uzbekistan IIV Markaziy Poliklinika, Tashkent, Uzbekistan Toshkent viloyat IIV Poliklinika, Tashkent, Uzbekistan |